Stay updated on Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.

Latest updates to the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page
- Check4 days agoChange DetectedSupplementary multiple myeloma resource references were removed, and the ClinicalTrials.gov site revision advanced from v3.8.0 to v3.8.1.SummaryDifference0.2%

- Check11 days agoChange DetectedThe clinical-trial record for a carfilzomib, iberdomide, and dexamethasone study in transplant-eligible multiple myeloma is displayed, with its status listed as suspended pending amendment approval. The record also provides study design, participant criteria, treatment details, locations, and measures.SummaryDifference80%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check32 days agoChange DetectedAn NIH-wide notice about website updates and a shift in terminology from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

Stay in the know with updates to Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.